| Ytd | 17.39% | |
| 1y | 0.78% |
| Open | 91.73 | Prev Close | 91.68 | Low | 91.52 | High | 92.83 | Mkt Cap | 74.23B |
| Vol | 2.93M | Avg Vol | 5.41M | EPS | 2.58 | P/E | 35.95 | Forward P/E | 22.94 |
| Beta | 0.32 | Short Ratio | 3.93 | Inst. Own | 87.94% | Dividend | 2.12 | Div Yield | 2.31 |
| Ex Div Date | 07-20 | Earning | 07-31 | 50-d Avg | 88.37 | 200-d Avg | 84.70 | 1yr Est | 95.85 |
CL stock's strength reflects solid momentum, but inflation, North America softness and a premium val
Bernstein analyst Cristian Rios initiates coverage on Colgate-Palmolive (NYSE:CL) with a Market P
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and r
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and rai
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ
RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintai
Colgate warns Middle East conflict is driving up costs and hitting global spending. Get the full bre
Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20
Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.97 per share which beat the analyst co
Colgate-Palmolive (CL) will release Q1 earnings on May 1. Analysts expect 94 cents/share, up from 91
U.S. stocks close higher, CAT and GOOGL shares jump 10% after earnings, while META and MSFT shares d
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and
Rothschild & Co analyst Edward Lewis upgrades Colgate-Palmolive (NYSE:CL) from Neutral to Buy
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and low
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and l
B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and low
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and low
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price targ
Deutsche Bank analyst Steve Powers upgrades Colgate-Palmolive (NYSE:CL) from Hold to Buy and rais
Judge Boyle throws out Elon Musk's antitrust lawsuit against WFA, Nestle, Shell, Mars, CVS, and
U.S. equities fell broadly Wednesday as Brent Crude surged past $108 on reports of Iranian energy-fa
As part of the previously announced Strategic Growth and Productivity Program, to further optimize a
The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the qua
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and r
Jefferies analyst Kaumil Gajrawala maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises t
Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and rai
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and rai
Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive (NYSE:CL) with a Outperf
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and
B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and rai
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and
Deutsche Bank analyst Steve Powers maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises t
Colgate-Palmolive beats fourth-quarter expectations on strength in oral care and pet nutrition, but
Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.95 per share which beat the analyst co